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Objectives: While decision analysis and treatment algorithms have repeatedly been shown to improve quality of care in
many areas of medicine, no such algorithm has emerged for the invasive management of lower extremity peripheral
arterial disease. Using the best available evidence-based outcomes data, our group designed a standardization tool, the
Lower Extremity Grading System (LEGS) score, which consistently directs limbs to a specific treatment on the basis of
presentation. The purpose of this study was to examine whether use of such a tool improves outcomes by directing
treatment of lower extremity peripheral arterial disease.
Methods: Over 18 months (July 2001-December 2002) our group intervened in 673 limbs (angioplasty, open surgery,
primary limb amputation) with lower extremity peripheral arterial disease. During this time we developed the LEGS
score, and implemented its prospective use for the final 362 limbs. For the purpose of this study, all 673 limbs were
retrospectively scored with the LEGS score to determine the LEGS recommended best treatment. Of the 673 limbs, 551
(81.9%) received the same treatment as recommended with LEGS and 122 (18.1%) received treatment contrary to LEGS.
Limbs treated contrary to LEGS (cases) were then compared with matched control limbs (treated according to LEGS),
with similar angiographic findings, clinical presentation, preoperative functional status, comorbid conditions and
operative technical factors. Outcomes measured at 6 months included arterial reconstruction patency, limb salvage,
survival, and maintenance of ambulatory status and independent living status. Kaplan-Meier curves were used to assess
patency, limb salvage, and survival; associated survival curves were compared with the log-rank test. Functional outcomes
were compared with the Fisher exact test.
Results: After matching case limbs with control limbs, 9 limbs had no control match. Thus 113 limbs in 100 patients
treated contrary to LEGS were compared with 113 limbs in 100 patients treated according to LEGS. Limbs treated
contrary to LEGS resulted in significantly inferior outcomes at 6 months for measures of primary patency (57.5% vs
84.3%; P < .001), secondary patency (73.2% vs 96.2%; P < .001), limb salvage (89.7% vs 97.2%; P  .04), and
maintenance of ambulatory status (78% vs 92%; P  .02). As an additional finding, 29.6% (92 of 311) of interventions
performed before implementation of the algorithm were treated contrary to LEGS, and thus contrary to objectively
determined best therapy, compared with 8.3% (30 of 362) after LEGS implementation (P < .001).
Conclusions:Limbs treated according to our standardization tool resulted in better outcomes comparedwith limbs treated
contrary to the algorithm. These data suggest that routine use of an appropriately validated treatment standardization
algorithm is capable of improving overall results for invasive treatment of lower extremity peripheral arterial disease.
(J Vasc Surg 2004;40:907-15.)With the explosion of endovascular alternatives, the
management of symptomatic lower extremity arterial oc-
clusive disease has become an increasingly confusing en-
deavor, producing a conundrum regarding the best invasive
treatment in any given patient. In addition, the prolifera-
tion of endovascular interventions has led to an increasing
number of specialists available to treat lower extremity
peripheral arterial disease (PAD), with each specialty carry-
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doi:10.1016/j.jvs.2004.08.046ing its own bias regarding the best treatment option. While
decision analyses and treatment algorithms have repeatedly
been shown to improve the quality of care in many areas of
medicine,1-3 no universally accepted algorithm has
emerged to direct the invasive treatment of lower extremity
PAD. Using the best available evidence-based outcomes
data, our vascular group designed a standardization tool,
the Lower Extremity Grading System (LEGS) score, which
consistently directs limbs to a specific type of treatment
(open surgery, endovascular intervention, primary amputa-
tion) on the basis of several objective measures (Table I). A
previous study from our institution demonstrated that this
tool is easy to use and relatively immune to intergrader
bias.4 Another has documented that favorable outcomes
can be achieved when patients are treated according to
LEGS compared with established standards.5 What has not
been demonstrated, however, is that routine use of such a
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consequent to traditional decision making. The purpose of
this study therefore was to compare patient outcomes in
limbs treated as directed by the LEGS standardization
algorithm with those treated contrary to the LEGS algo-
rithm, to determine whether use of such a tool improves
overall outcomes.
MATERIAL AND METHODS
LEGS score. The LEGS score algorithm is a treat-
ment standardization system developed with the best avail-
able evidence3,5-7 to consistently direct invasive therapy for
symptomatic lower extremity PAD. It is comprised of 5
categories, including arteriographic findings, clinical pre-
sentation, preoperative functional status of the patient,
associated medical comorbid conditions that affect treat-
ment decision, and technical factors specific to type of
treatment. Numeric points are assigned in each category,
and the sum of these points results in a total score, which
directs each limb to 1 of 3 treatment options. Patients with
a total LEGS score ranging from 0 to 9 points are recom-
mended for open bypass surgery, patients with a total
LEGS score ranging from 10 to 19 points are recom-
mended for endovascular therapy, and patients with a total
LEGS score greater than 20 points are recommended for
primary amputation. A detailed description of the LEGS
Table I. Lower extremity grading system score
Arteriographic findings Presentation Funct
Aortic Claudication 5 Ambu
 3 cm aortic stenosis/
occlusion or 3–5 cm
stenosis of aortoiliac
bifurcation
8 Limb-threatening
ischemia
2 Ambu
hom
3 cm aortic
stenosis/occlusion or 5
cm stenosis of aortoiliac
bifurcation
0 Nonam
tran
Nonam
Iliac
TASC A or B 8
TASC C 2
TASC D 0
Femoral-popliteal-tibial
 5 cm occlusion/stenosis 5
 5 cm occlusion with
distal target
0
Isolated common/deep
femoral stenosis
0
 5 cm occlusion without
distal target
6
Possible score 0-8 2-5
Recommended treatment (sum of total score from each column): 0-9, open
ulcer or end-stage renal disease are present, double the score.
TASC, TransAtlantic Inter-Society Consensus.
*As derived by the Eagle Criteriascore, definitions of its components, and its appropriateapplication have been published.4 Limbs are scored only
when the treating physician has decided that medical ther-
apy has failed and that invasive therapy (revascularization) is
necessary. Treatment after scoring proceeds with the prin-
ciple of correcting proximal disease before distal disease.
For example, in a patient with a short-segment iliac steno-
sis, a superficial femoral artery occlusion, and a nonhealing
foot ulcer, the LEGS score would grade the limb with
emphasis on the proximal disease first. If after treatment of
the iliac stenosis the limb was still at risk, and in the
judgment of the treating physician in need of further inter-
vention, the limb would be re-scored to determine the best
treatment for the femoral artery occlusion. Limbs are
scored and treated independent of each other, except when
both limbs have indications for invasive therapy and bilat-
eral aortoiliac occlusive disease is present.
The LEGS score was developed from September 2001
through February 2002, and was available to all members
of our vascular faculty in March 2002. However, use of the
LEGS score and adherence to its recommendations was not
mandated. Limbs that were scored and treated according to
LEGS were prospectively entered into a database, the out-
comes of which have been reported.5
Patient and study population. Over the 18 months
from July 2001 through December 2002, our group inter-
vened in 673 limbs with lower extremity PAD in 496
status
Comorbid
conditions Technical factors
0 Obesity 2 All cases
Repeat surgery
2
/at
ly
2 High risk coronary
artery disease*
3 Repeat angioplasty 2
tory/
nly
5 Age (y)
70
1 Infrainguinal cases
Blind segment
target
2
tory 20  80 2 No venous
conduit
6
No vein, with foot
infection
8
0-20 0-7 2-12
ery; 10-19, endovascular intervention;  20, primary amputation. If a heelional
latory
latory
e on
bula
sfer o
bula
surgpatients who survived at least 30 days. After institutional
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analyzed and found to have an average age (SD) of 65.04
 11.87 years (range, 32-94 years). The group consisted of
198 women (39.9%) and 298 men (60.1%), of whom 97
(19.6%) were African American, 3 were Hispanic (0.60%),
and 396 were white (79.8%). Severe claudication (Ruther-
ford category 3) was the clinical indication for intervention
in 222 patients (44.89%), and critical limb ischemia (Ruth-
erford category 4 or 5) was the indication for intervention
in the remaining 274 patients (55.2%).
Of the 673 limbs treated, 260 were treated with open
procedures, 388 were treated with endovascular interven-
tions, and 25 were treated with primary amputation. In the
260 limbs treated with open surgery there were 24 aorto-
bifemoral bypasses (48 limbs), 2 aortofemoral bypasses (2
limbs), 6 aortobiiliac bypasses (12 limbs), 4 axillobifemoral
bypasses (8 limbs), 2 axillofemoral bypasses (2 limbs), 10
femorofemoral bypasses (10 limbs), 2 iliofemoral bypasses
(2 limbs), 2 iliac endarterectomies (2 limbs), 7 common
femoral endarterectomies (7 limbs), and 167 femoral-pop-
liteal-tibial bypasses (159 with autogenous vein, 8 with
polytetrafluoroethylene conduit). Of the 388 limbs treated
with therapy (with or without stenting) there were 228
aortoiliac angioplasties (228 limbs) and 160 femoral-
popliteal-tibial angioplasties (160 limbs). All 25 primary
amputations were above the knee.
Study design. For the purpose of this study, all 673
limbs treated during the study period were retrospectively
scored with the LEGS score, to determine the LEGS rec-
ommended best treatment. The vascular database was then
independently reviewed to retrieve the actual treatment
offered in each of these cases. Of the 673 limbs, 551 limbs
(81.9%) received the same treatment as recommended by
LEGS, and 122 limbs (18.1%) received treatment contrary
to LEGS recommendation. A case-control study design
was then used to compare outcomes between patients with
limbs treated contrary to the LEGS recommendation (case
limbs) with outcomes in patients with limbs treated accord-
ing to the LEGS recommendation (control limbs). Case
limbs were matched to control limbs on the basis of similar
angiographic findings (TransAtlantic Inter-Society Con-
sensus classification6,7), clinical presentation (claudication,
critical limb ischemia), preoperative functional status
(LEGS criteria4), extent of coronary artery disease (Eagle
criteria8), and other medical comorbid conditions (ad-
vanced age, obesity, special technical considerations as de-
fined with LEGS critera4). When more than 1 control was
eligible for matching to a case, only 1 control was randomly
selected for inclusion. Nine limbs were found to have no
match, as a result of demographic or arteriographic differ-
ences, and thus were excluded from the analysis. Thus 113
limbs in 100 patients treated contrary to LEGS were com-
pared with 113 limbs in 100 patients treated according to
LEGS, using outcomes measured at 6 months after inter-
vention.
Outcome measures. All patients underwent similar
follow-up, which consisted of a clinic visit, ankle-brachial
index determination, and lower extremity duplex ultra-sound scanning at 1, 3, and 6 months after intervention.
Outcomes measures included arterial reconstruction, pri-
mary and secondary patency rates; limb salvage; survival;
maintenance, improvement, or deterioration of preopera-
tive ambulatory status; and maintenance or deterioration of
independent living status. For the purpose of this analysis,
failing arterial reconstructions treated before thrombosis
were grouped with reconstructions that thrombosed and
were salvaged for secondary patency. A failed open opera-
tion was defined as thrombosis of the bypass graft or
endarterectomy site as detected at physical examination and
confirmed at duplex ultrasound scanning or contrast mate-
rial–enhanced arteriography. A failed angioplasty was de-
fined as thrombosis of the treated vessel as detected at
physical examination and confirmed at duplex ultrasound
scanning, or deterioration in the ankle-brachial index to
within 0.15 of the pretreatment value. Functional out-
comes were measured as previously reported.4 Change in
ambulatory status after intervention was defined as any
change in the patient’s LEGS functional status classification
(Table I). Preoperative living status for each patient was
determined and categorized as living independently at
home, living in an assisted living environment, or living in a
nursing home. An assisted living environment was defined
as a communal dwelling that allows independent apartment
living, but in a facility that centrally provides meals, activi-
ties, and routine functional assistance. Change in indepen-
dent living status was defined as change from one category
to another.
Statistical analysis. Kaplan-Meier life table analysis
was used to assess patency, limb salvage, and survival, and
the associated survival curves were compared with the
log-rank test. Functional outcomes and categoric demo-
graphic characteristics (eg, diabetes, coronary disease) were
compared with the Fisher exact test (comparison of propor-
tions). Mean age was compared with the Student t test for
independent groups.9
RESULTS
A comparison of patient demographic data, disease
patterns, and treatments between the 113 limbs in 100
patients treated according to LEGS and the 113 limbs in
100 patients treated contrary to LEGS is shown in Table II.
As expected, there were no differences in matched variables
between groups. In addition, there was no difference in
age, race, smoking history, or diabetes. There was a differ-
ence, however, in gender distribution; the LEGS group
included a higher percentage of men (74% vs 58%; P 
.025). Also as expected, the groups differed by type of
treatment performed. Seventy-two percent of of limbs in
the non-LEGS group underwent endovascular treatment,
compared with 28% of limbs in the LEGS group.
The LEGS score was developed in late 2001 by our
vascular faculty in an attempt to standardize treatment so
that the best therapy, based on consensus opinion and the
most current literature,6,7,10 would consistently be recom-
mended for consideration to the treating physician. The
score was available for voluntary use in March 2002. Of
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treated were treated contrary to LEGS and thus contrary to
objectively determined best therapy, compared with 30 of
362 limbs (8.3%) after March, a difference that was statis-
tically significant (P  .001).
Clinical outcomes. Arterial reconstruction primary
and secondary patency at 6 months comparing limbs
treated according to LEGS to those treated contrary to
LEGS are shown in Fig 1. Limbs treated contrary to LEGS
performed significantly worse than control limbs treated
according to LEGS for both primary patency (57.5% vs
84.3%; P  .001) and secondary patency (73.2% vs 96.2%;
P  .001).
Limb salvage at 6 months comparing cases treated
contrary to LEGS with case control limbs treated according
to LEGS is shown in Fig 2. There were a total of 4 major
limb amputations in the LEGS group, and 11 in the non-
LEGS group. There were no instances where an interven-
tion for claudication resulted in major limb amputation in
either group. Limbs treated contrary to LEGS had signifi-
cantly inferior limb salvage rates compared with control
limbs treated according to LEGS (89.7% vs 97.2%; P 
.04). Survival at 6 months comparing the 2 groups is shown
in Fig 3. There was no statistically significant survival dif-
ference between case limbs treated contrary to LEGS and
control limbs treated according to LEGS (87.9% vs 96.8%;
P  .12).
In an attempt to analyze the reason for the differences
in patency and limb salvage between groups, the results by
type of treatment (endovascular, non-LEGS vs LEGS and
Table II. Comparison of cases (113 limbs in 100 patients
in 100 patients treated according to LEGS)
Mean LEGS Score (SD)
Mean age (y) (SD)
Sex (female/male)
Race (black/white)
Smoking history (%)
Diabetes (%)
High cardiac risk* (%)
Presentation (%)
Claudication
Limb-threatening ischemia
Level of disease (%)
Aortoiliac
Infrainguinal
Extent of disease (%)
Aortoiliac TASC A or B
Aortoiliac TASC C or D
Infrainguinal TASC A or B
Infrainguinal TASC C or D
Treatment with open surgery (% limbs)
Treatment with endovascular intervention (% limbs)
LEGS, Lower Extremity Grading System score; TASC, TransAtlantic Inter-
*Eagle score  3.
†Matchedopen surgery, non-LEGS vs LEGS) were compared (TableIII). Treatment as directed with LEGS was generally supe-
rior to treatment performed contrary to LEGS, regardless
of whether endovascular or open surgery was performed.
Functional outcomes. Maintenance or improvement
in ambulatory status and maintenance of independent liv-
ing status after treatment are shown in Fig 4. There was a
statistically significant decline in the percentage of patients
able to maintain or improve their ambulatory status after
treatment in patients treated contrary to LEGS compared
with patients treated according to LEGS (78% vs 99.2%; P
 .02). There was no statistically significant difference in
the percentage of patients able to maintain their indepen-
dent living status after treatment when comparing treat-
ment contrary to LEGS with patients treated according to
LEGS (85% vs 94%; P  .10). Table III illustrates that,
whereas patients in the LEGS group experienced better
overall functional outcomes than patients in the non-LEGS
group, regardless of treatment, the most significant im-
provement occurred with ambulatory ability in patients
undergoing open surgery (LEGS open surgery 91.8% vs
non-LEGS open surgery 74.1%; P  .039).
DISCUSSION
Most clinicians involved in management of lower ex-
tremity PAD consider optimal treatment to be profession-
ally intuitive. This premise was challenged within our own
group when we learned that patients referred for interven-
tion often received treatment according to which physician
they saw, not by which treatment was best supported by
outcomes reported in the literature. Physicians more in-
ted contrary to LEGS) and matched controls (113 limbs
reatment
ing to LEGS
Treatment
contrary to LEGS P
.3  3.7 7.3  3.7 1.00
rs  12.36 64.4  10.93 0.33
26/74 42/58 0.025
16/84 23/77 0.28
63 63 1.00
57 43 0.07
14 14 1.0†
45 45 1.0†
55 55 1.0†
32 32 1.0†
68 68 1.0†
33 33 1.0†
67 67 1.0*
35 35 1.0*
65 65 1.0*
71.7 28.3 0.001
28.3 71.7 0.001
y Consensus.trea
T
accord
7
66 y
Societclined to endovascular intervention tended to offer endo-
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 5 Androes et al 911vascular therapy, and physicians more inclined to open
surgery tended to offer open surgery. Troubled by this, and
aware of the many evidence-based algorithms and decision
Fig 1. Comparison of arterial reconstruction patency ra
limbs in 100 patients treated according to Lower Extr
patients treated contrary to LEGS.analyses geared toward optimizing patient care, we devel-oped the LEGS score. This treatment standardization tool
was made available to the members of our group in March
2002 for voluntary use and prospective evaluation. This
6 months with Kaplan-Meier life table analysis for 113
Grading System (LEGS) score and 113 limbs in 100tes at
emityreport represents our third study of the LEGS score. Our
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treated according to Lower Extremity Grading System (LEGS) score and 113 limbs in100 patients treated contrary to
LEGS.Fig 3. Comparison of survival rates at 6 months with Kaplan-Meier life table analysis for 100 patients treated
according to LEGS and 100 patients treated contrary to LEGS.
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ability of the scoring system.4 The second study tested to
see whether the standardization tool, when followed, could
actually direct treatment that would result in acceptable
outcomes.5 The current study sought to determine
whether using such a system could actually make a differ-
ence in patient outcomes, compared with an “intuitive”
approach of directing treatment. Our findings before this
report suggested that LEGS is easy to use, results in con-
sistent scoring even among graders with different treatment
perspectives for lower extremity PAD, and predicts favor-
able outcomes compared with established standards.3,4
This study, a retrospective case-control comparison of
limbs treated contrary to the LEGS score and limbs treated
according to the LEGS score, found that treatment di-
Fig 4. Comparison of functional outcomes at 6 month
LEGS and 100 patients treated contrary to LEGS.
Table III. Comparison of 113 limbs in 100 patients treat
contrary to LEGS, stratified by treatment approach (endov
Outcome at 6 mo according to
treatment group
Treatment
%
Endovascular intervention
Primary reconstruction patency 87.0
Secondary reconstruction patency 89.9
Limb salvage 96.7
Survival 96.3
Maintenance of ambulatory status 92.6
Maintenance of living status 92.6
Open surgery
Primary reconstruction patency 83.3
Secondary reconstruction patency 98.7
Limb salvage 97.3
Survival 97.0
Maintenance of ambulatory status 91.8
Maintenance of living status 94.5
Note: Primary patency, secondary patency, limb salvage, and survival prop
confidence intervals for maintenance of ambulatory and living status were o
LEGS, Lower Extremity Grading System score; CI, confidence interval.
*Statistical significancerected by our standardization tool resulted in statisticallybetter clinical and functional outcomes than in limbs
treated contrary to the tool’s recommendation. Advantages
were seen for arterial reconstruction patency, limb salvage,
and maintenance of ambulatory ability. Furthermore, both
endovascular procedures and open operations as directed
by LEGS fared better than endovascular and open opera-
tions when treated contrary to LEGS. The findings of this
study seem to support the concept that routine use of a
standardization tool such as LEGS will result in better
overall outcomes.
While we believe the findings of the report are encour-
aging, enthusiastic support for the wholesale application of
the LEGS score should be tempered by the limitations cited
in our previous reports5 and by the obvious limitations of
the current study design. This is a retrospective trial, per-
Fisher exact test for 100 patients treated according to
cording to LEGS to 113 limbs in 100 patients treated
lar and open surgery)
ding to LEGS Treatment contrary to LEGS
95% CI % 95% CI
75.1, 98.9 54.7 43.4, 66.0*
78.9, 100 74.8 65.0, 84.6
90.3, 100 92.0 85.8, 98.2
89.2, 100 86.2 78.3, 94.1
75.7, 99.1 79.5 68.4, 88.0
75.7, 99.1 83.6 73.0, 91.2
75.0, 91.6 63.6 47.2, 80.0
96.2, 100 69.7 54.0, 85.4*
93.7, 100 84.4 71.8, 97.0
92.9, 100 92.6 82.7, 100
83.0, 96.9 74.1 53.7, 88.9
86.6, 98.5 88.9 70.8, 97.6
s were obtained with Kaplan-Meier life table analysis. Ninety-five percent
d with the Fisher exact test.s withed ac
ascu
accor
ortion
btaineformed at a single institution, using a standardization tool
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sions based on extremely short (6 months) follow-up. It
also can be argued that, while we have shown statistically
significant differences between the study populations, one
could question whether clinically important differences
truly exist. Comparing LEGS-directed interventions with
interventions contrary to LEGS represents an analysis of
opposite extremes. After looking at the LEGS score in
detail, it is difficult to imagine that any group of well-
trained vascular specialists would consistently perform ev-
ery treatment opposite to the recommendations of LEGS.
Even when our most avid critics have pointed out the
weaknesses of some of the LEGS recommendations, most
concede that the scoring system directs the most common
presentations toward mainstream therapy. For example,
unilateral short-segment iliac artery stenosis in patients with
claudication scores for angioplasty. Long-segment femoral
artery occlusions in limb salvage situations score for bypass.
Thus a pure population of non-LEGS treated limbs is
unlikely to ever occur. It is reasonable to argue, then, that
this study represents an implausible comparison of unlikely
populations. While this may be true, the findings of this
study should not be dismissed. We were struck by our own
group’s practice patterns before development of the LEGS
score. Before LEGS our group, the same group who con-
structed the algorithm on the basis of consensus of what
each considered best objective therapy, performed nearly a
third of its cases contrary to LEGS. Thus it is conceivable,
and likely, to picture a scenario where the number of
non-LEGS cases could accumulate to a point where it
would detrimentally affect the outcomes of the aggregate
population. Perhaps the most powerful testimony to the
regulatory influence of the standardization tool in this
study was the reduction in the number of non-LEGS cases
after development and voluntary implementation of the
LEGS score. The number of limbs treated contrary to
LEGS, and thus contrary to best objective therapy, de-
creased by 350%, a difference that was statistically signifi-
cant and clinically important.
In this study we chose to examine clinical and func-
tional outcomes with the LEGS standardization score. We
did not examine utilization data (eg, cost, hospital length of
stay), which we admit is a limitation of the study design.
However, for nearly 2 decades hospital-based care maps
have infiltrated our practices and have been repeatedly
touted as care standardization tools that result in more
cost-efficient hospital usage. It is intuitive to assume that a
well-studied algorithm that standardizes the interventional
approach to lower extremity PAD will ultimately improve
hospital usage. Intuition aside, however, this study was not
designed to examine this. A prospective study looking at all
aspects of care in these patients (preoperative evaluation,
hospital care, longitudinal follow-up care) would be helpful
and interesting.
Last, we attempted to determine why patients in the
non-LEGS group performed inferiorly to patients in the
LEGS group with our analysis in Table III. Looking at thetreatment differences between the 2 patient cohorts (Table
II), our initial belief was that results from limbs treated
contrary to LEGS were perhaps the byproduct of inappro-
priate “endo-exuberance.” More than 70% of limbs in this
category were treated with angioplasty and stenting. Of
interest, however, Table III shows that patients in the
non-LEGS group performed inferiorly to patients in the
LEGS group, regardless of treatment, endovascular or open
surgery. It appears that the inferior results cannot simply be
explained by inappropriate angioplasty. We conclude that
these findings are a testimony to standardization. An inap-
propriate procedure would most likely result in poorer
outcomes. A standardization algorithm therefore should
direct care that will achieve superior outcomes, and indeed
we believe that this is exactly what happened.
In summary, the LEGS score continues to be the only
prospectively studied standardization tool for the invasive
treatment of lower extremity PAD. The findings of this
report demonstrate that limbs treated according to the
LEGS score resulted in better clinical and functional out-
comes than limbs treated contrary to the LEGS algorithm.
As well, the LEGS score voluntary implementation signifi-
cantly changed the practice patterns of an experienced
group of vascular specialists. We therefore conclude that
routine use of an appropriately tested algorithm such as
LEGS is capable of improving overall results for invasive
treatment of lower extremity PAD.
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Dr Brian G. Rubin (St Louis, Mo). First, I really want to
recognize the authors’ attempts to provide an evidence-based
management algorithm for the treatment of lower extremity isch-
emia, but I have several questions.
Their group is recognized for excellence in both clinical and
endovascular care. My first question is, since other practitioners or
groups may not share your level of expertise in either endovascular
or open interventions, doesn’t each surgeon really have to generate
his or her own personalized LEGS scoring system and treatment
protocol based on their own outcomes? Or worded differently, I
suspect that your outcomes, good or bad, may be different from
those of practitioners with a different set of endovascular and open
skills, which would mean that your group’s results, while interest-
ing, may not be generalizable to the community as a whole.
Next, most of the LEGS violations, if I can use that term,
occurred when patients were treated with an endovascular ap-
proach when the protocol suggested that an open operation would
have been superior. Despite that, 55% of those patients’ endovas-
cular reconstructions were primarily patent, with a 75% secondary
patency rate. That means that three fourths of the LEGS violators
were spared open surgery while still achieving reconstructive pa-
tency. And I suspect that from a patient’s perspective that was a risk
worth taking. So was erring in favor of an endovascular approach
first really so undesirable?
Third, I have a problem with the comparison groups. For
example, you compared the patients treated with open procedures
in accordance with LEGS protocol versus those with open surgery
contrary to the LEGS protocol. But I’m not sure that that’s really
the appropriate group. It seems to me that what you wanted to do
was compare the open surgery patients treated contrary to LEGS
versus those with identical LEGS scores treated via an endovascular
route. And then the opposite comparison should be done for the
endovascular LEGS violators. Did you do those comparisons, and
what were the outcomes?
And last, after applying this algorithm for more than 2 years,
have you identified certain specific combinations that you now
recommend treating off protocol?
Dr Mark P. Androes. In terms of your first question, the
different experience, obviously every group has to take into ac-
count their own clinical abilities. We appreciate Dr Rubin’s infer-
ence that our endovascular expertise exceeds what is attainable
elsewhere. However, if this is the case now, we believe that as
endovascular surgery becomes more commonplace it will not be so
in the future. We also believe that many centers do not yet
appreciate the need for a standardization tool, probably because ofthe lack of their endovascular program differentiation at this time.
As this changes, they will appreciate the need for such a tool.
Your second question dealt with outcomes, and you asked, in
essence, is it acceptable to justify a decreased patency rate for
endovascular surgery to save the patient the morbidity of open
surgery? This is a very good question, not dissimilar from asking
whether it is justifiable to use a prosthetic conduit instead of vein
for a femoropopliteal bypass because the former procedure is less
morbid and leaves the vein bypass as a later viable option. While we
can debate this, we believe that third-party payers, and ultimately
the consumers, our patients, will demand the best, most durable,
and most cost-effective treatment first. This, of course, was one of
the motivators for the LEGS score.
In terms of comparing our study groups, we believe you are
mistaken. What you suggest we compare, patients with the same
LEGS score who received contrary treatments, is exactly what we
did compare.
And your last question was regarding patients to treat off
protocol. We have not found any patients who should not be
scored with LEGS to help direct best treatment.
Dr Enrico Ascher (Brooklyn, NY). Maybe I didn’t under-
stand the protocol very well, but do you mean to say that a
femoropopliteal bypass with vein is better than 2 angioplasties
within the same period of time that could be done mostly on an
ambulatory basis?
Dr Androes. I believe so.
Dr Ascher. Why is that?
Dr Androes. I think, in terms of outcomes, there are clinical
situations where results such as primary or secondary patency
justify femoropopliteal bypass rather than multiple angioplasties.
Dr Ascher. I know. But the patients are not looking at
primary or secondary patency. They’re looking into something
minimally invasive that can get them back to work as soon as
possible and that is not so painful or aggressive.
Dr Androes. I think the other thing to look at is cost and
durability. While patients may prefer minimally invasive therapy,
they also prefer having 1 procedure and not having to worry about
it anymore. Which is more valuable, minimally invasive or durable
surgery, is a matter of conjecture that deserves study.
Dr Ascher. I just think we have to be a little more realistic in
this era in which we are now in competition with everyone, and
believe that the way you’re looking into procedures cannot be the
same as we used to look before, with 5-year patency rates; rather, it
was the most expeditious and most cost-effective procedure, and
we just have to change a little bit the way we think. That’s my
opinion.
